Sarcoma  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

10 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00047177: Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor

Completed
2
43
US
Oxaliplatin
Pediatric Brain Tumor Consortium, National Cancer Institute (NCI)
Brain and Central Nervous System Tumors
08/04
07/07
NCT00091182: Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Completed
2
180
US
oxaliplatin, 1-OHP, Dacotin, Dacplat, Eloxatin, L-OHP
National Cancer Institute (NCI)
Childhood Central Nervous System Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor, Childhood Hepatoblastoma, Childhood Hepatocellular Carcinoma, Childhood High-grade Cerebral Astrocytoma, Childhood Low-grade Cerebral Astrocytoma, Childhood Malignant Ovarian Germ Cell Tumor, Childhood Malignant Testicular Germ Cell Tumor, Childhood Teratoma, Recurrent Adrenocortical Carcinoma, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Ependymoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Malignant Germ Cell Tumor, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Childhood Visual Pathway and Hypothalamic Glioma, Recurrent Colon Cancer, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Nasopharyngeal Cancer, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Rectal Cancer, Recurrent Renal Cell Cancer
02/06
 
NCT00407433: Clinical Studies of Gemcitabine-Oxaliplatin

Completed
2
156
Europe
Gemcitabine (Gemzar®), Oxaliplatin (Eloxatin®)
Gustave Roussy, Cancer Campus, Grand Paris
Medulloblastoma, Central Nervous System Tumors, Neuroblastoma, Osteosarcoma
 
 
NCT00954876: Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal Cancer

Withdrawn
2
0
US
capecitabine and cetuximab
Translational Genomics Research Institute, Eli Lilly and Company
Metastatic Colorectal Cancer
01/10
01/10
2009-017437-22: MANAGEMENT OF PRIMARY AND SECUNDARY PERITONEAL CARCINOMATOSIS FROM COLO-RECTAL CANCER, RECURRENT OVARIAN CANCER AND ABDOMINAL SARCOMATOSIS BY CYTOREDUCTIVE SURGERY PLUS HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY

Ongoing
2
60
Europe
Solvent for parenteral use, Solution for injection, CISPLATINO TEVA*EV 50MG 100ML, ADRIBLASTINA*EV FL 10MG+F 5ML, MITOMYCIN C, ELOXATIN*INFUS 1FL 10ML 5MG/ML
AZIENDA OSPEDALIERA DI PERUGIA
Peritoneal carcinomatosis
 
 
NCT00819780 / 2008-004281-71: PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors

Checkmark ECC 2015
Sep 2015 - Sep 2015: ECC 2015
Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Checkmark For 1st line treatment of mCRC pts with wild-type KRAS tumors
More
Completed
2
285
Europe, Canada, US
Panitumumab, Vectibix, Bevacizumab, Avastin, mFOLFOX6
Amgen
Colon Cancer, Colorectal Cancer, Rectal Cancer, Metastatic Colorectal Cancer
05/12
07/16
NCT01327612 / 2010-022270-14: Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

Completed
2
12
Europe, US
Modified FOLFOX6, Oxaliplatin-Leucovorin-Fluorouracil chemotherapy, Conatumumab, AMG 655, Ganitumab, AMG 479, Bevacizumab, Avastin
Amgen
Advanced Solid Tumors, Carcinoid, Colorectal Cancer, Locally Advanced, Lymphoma, Metastatic Cancer, Non-Small Cell Lung Cancer, Sarcoma, Solid Tumors
02/20
02/20
Pan-MSI-ACSE, NCT06333314: Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

Not yet recruiting
2
120
Europe
Dostarlimab, Chemotherapy
UNICANCER, National Cancer Institute, France, GlaxoSmithKline
Pancreatic Adenocarcinoma, Ampulla of Vater Carcinoma, Adrenocortical Carcinoma, Neuroendocrine Carcinoma, Soft Tissue Sarcoma, Small Bowel Adenocarcinoma, Duodenum Adenocarcinoma, Gastric Adenocarcinoma
10/28
09/30
NCT00005856: Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Terminated
1/2
59
US
oxaliplatin, 1-OHP, Dacotin, Dacplat, Eloxatin, L-OHP, pharmacological study, pharmacological studies
National Cancer Institute (NCI)
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
01/07
 
NCT03009058 / 2016-001459-28: Study of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable Cancer

Terminated
1/2
2
Europe
IMM-101, Heat killed M. obuense (NCTC) 13365), Gemcitabine, GEMZAR, Nabpaclitaxel, Abraxane, Capecitabine, Folinic Acid, Leucovorin, Fluorouracil, 5FU, Irinotecan, Campto, Camptosar, Oxaliplatin, Eloxatin, cetuximab, Erbitux, Anti-PD1, pembrolizumab (KEYTRUDA),, nivolumab (OPDIVO), Ipilimumab, YERVOY, Cyclophosphamide, cytophosphane
Immodulon Therapeutics Ltd
Metastatic Cancer
08/17
08/17

Download Options